Cervical Cancer Diagnostic Testing Market by Diagnostic Test Type (Cervical Biopsy, Colposcopy, Endocervical Curettage, HPV Typing, Leep, Pap Smear Testing), and Imaging Tests for Stage Detection (CT or CAT, MRI, PET, Chest X-Ray) and Forecast 2017-2021

Cervical Cancer Diagnostic Testing Market by Diagnostic Test Type (Cervical Biopsy, Colposcopy, Endocervical Curettage, HPV Typing, Leep, Pap Smear Testing), and Imaging Tests for Stage Detection (CT or CAT, MRI, PET, Chest X-Ray) and Forecast 2017-2021

Cervical cancer is caused due to HPV infection and Worldwide, it is the fourth-most common cause of cancer and the fourth-most common cause of deaths from cancer in women. Human papillomavirus infections are responsible for 90% of the cervical cancer cases. Cervical cancer is a medical condition in which cells present in the lining of the cervix, gradually develop into pre-cancerous mass of cells that ultimately turn into cancerous tumors. Two major types of cervical cancers that are typically screened and diagnosed in women include adenocarcinoma and squamous cell carcinoma.

The global cervical cancer diagnostic testing market report estimates the market size (Revenue USD million – 2014 to 2021) for market segmentation based on diagnostic test type (cervical biopsy, colposcopy, endocervical curettage, HPV typing, LEEP, pap smear testing, and imaging tests for stage detection such as CT or CAT, MRI, PET, chest X-ray, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).

The global cervical cancer diagnostic testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cervical cancer diagnostic testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global cervical cancer diagnostic testing market and included in this report are Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico Ltd., Guided Therapeutics, Inc., OncoHealth Corp.

sed on diagnostic test type (cervical biopsy, colposcopy, endocervical curettage, HPV typing, LEEP, pap smear testing, and imaging tests for stage detection such as CT or CAT, MRI, PET, chest X-ray, etc.), and forecasts growth trends (CAGR% – 2017 to 2021). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent acquisitions and alliances.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Diagnostic Test Type
    • Indication or Infection Type
    • Technology
    • Diagnostics Application
    • Service Type
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Cervical Cancer Diagnostic Tests Market

1. Diagnostic Test Type
1.1. Cervical Biopsy
1.2. Colposcopy
1.3. Endocervical Curettage (ECC)
1.4. Human Papilloma Virus (HPV) Typing
1.5. Loop Electro-surgical Excision Procedure (LEEP)
1.6. Pap Smear Testing
1.7. Others

2. Imaging Tests for Stage Detection
2.1. CT or CAT (Computed Axial Tomography)
2.2. MRI (Magnetic Resonance Imaging)
2.3. PET (Positron Emission Tomography)
2.4. Chest X-ray

2. Company Profiles
2.1. Abbott Laboratories
2.2. Becton, Dickinson and Company
2.3. F. Hoffmann-La Roche Ltd.
2.4. Femasys, Inc.
2.5. Guided Therapeutics, Inc.
2.6. Hologic, Inc.
2.7. OncoHealth Corp.
2.8. Qiagen N.V.
2.9. Quest Diagnostics, Inc.
2.10. Zilico Ltd.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »